Ed Iwanowicz

Dr. Iwanowicz is the founder and president of Madera Therapeutics. Ed has over 30 years of experience in drug discovery and development in leadership positions in large pharma (BMS, Novartis, and J&J), a large biotech (Chiron), and startups with venture backing. In addition, Dr. Iwanowicz was a partner at the Forward Medical Science Partners. He has contributed to programs yielding drugs for the treatment of cardiovascular, immunological, and oncological diseases, including Dasatinib®, Acumapimod®, Raf-265, and BMK-120.